留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

“四主题理论”在风湿免疫性疾病患者治疗决策中的实践与应用

戴晓敏 姜林娣

戴晓敏, 姜林娣. “四主题理论”在风湿免疫性疾病患者治疗决策中的实践与应用[J]. 协和医学杂志, 2021, 12(4): 589-593. doi: 10.12290/xhyxzz.20200171
引用本文: 戴晓敏, 姜林娣. “四主题理论”在风湿免疫性疾病患者治疗决策中的实践与应用[J]. 协和医学杂志, 2021, 12(4): 589-593. doi: 10.12290/xhyxzz.20200171
DAI Xiaomin, JIANG Lindi. Practice and Application of Four-topics Theory in Decision-making of Treatment Strategies in Patients with Rheumatic Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(4): 589-593. doi: 10.12290/xhyxzz.20200171
Citation: DAI Xiaomin, JIANG Lindi. Practice and Application of Four-topics Theory in Decision-making of Treatment Strategies in Patients with Rheumatic Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(4): 589-593. doi: 10.12290/xhyxzz.20200171

“四主题理论”在风湿免疫性疾病患者治疗决策中的实践与应用

doi: 10.12290/xhyxzz.20200171
基金项目: 

上海市教育科学研究一般项目 C2021243

详细信息
    通讯作者:

    姜林娣  电话:021-64041990,E-mail:zsh-rheum@hotmail.com

  • 中图分类号: R-052

Practice and Application of Four-topics Theory in Decision-making of Treatment Strategies in Patients with Rheumatic Diseases

Funds: 

Shanghai Educational Science Research General Projects C2021243

More Information
  • 摘要: 本文通过临床伦理学视角,探讨风湿免疫性疾病患者临床治疗决策中的伦理问题及应对策略。采用“四主题理论”模型,分别从医疗适用性、患者偏好、生命质量、情境特征等主题切入,提炼伦理问题,查找循证证据,倾听患者意愿,促进医患双方共同参与、决策临床问题。
    作者贡献:戴晓敏负责文章撰写;姜林娣负责文章审阅与修订。
    利益冲突:
  • 图  1  临床伦理学“四主题理论”在风湿免疫性疾病案例中的具体应用

  • [1] Jonsen AR. A short history of medical ethics[M]. New York: Oxford University Press, 1999.
    [2] 张新庆, 李传俊, 蔡笃坚. 30年来我国临床伦理研究主题之特点与反思——基于《中国医学伦理学》刊登论文的分析[J]. 中国医学伦理学, 2018, 31: 461-464. https://www.cnki.com.cn/Article/CJFDTOTAL-XNLX201804015.htm

    Zhang XQ, Li CJ, Cai DJ. Characteristic of the Research Themes and Reflections on Clinical Ethics in China within Thirty Years: An Analysis Based on the Published Paper of Chinese Medical Ethics[J]. Zhongguo Yixue Lunlixue, 2018, 31: 461-464. https://www.cnki.com.cn/Article/CJFDTOTAL-XNLX201804015.htm
    [3] Jonsen AR, Siegler M, Winslade WJ. Clinical ethics: a practical approach to ethical decisions in clinical medicine[M]. 8th ed. New York: McGraw-Hill Education, 2015.
    [4] Shaban A, Leira EC. Neurological Complications in Patients with Systemic Lupus Erythematosus[J]. Curr Neurol Neurosci Rep, 2019, 19: 97. doi:  10.1007/s11910-019-1012-1
    [5] Bertsias GK, Ioannidis JP, Aringer M, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs[J]. Ann Rheum Dis, 2010, 69: 2074-2082. doi:  10.1136/ard.2010.130476
    [6] Ruiz-Arruza I, Lozano J, Cabezas-Rodriguez I, et al. Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus and Prevention of Damage Without Worsening Long-Term Disease Control: An Observational Study[J]. Arthritis Care Res(Hoboken), 2018, 70: 582-591. doi:  10.1002/acr.23322
    [7] Legge A, Doucette S, Hanly JG. Predictors of Organ Damage Progression and Effect on Health-related Quality of Life in Systemic Lupus Erythematosus[J]. J Rheumatol, 2016, 43: 1050-1056. doi:  10.3899/jrheum.150985
    [8] Dubovsky AN, Arvikar S, Stern TA, et al. The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited[J]. Psychosomatics, 2012, 53: 103-115. doi:  10.1016/j.psym.2011.12.007
    [9] Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus[J]. Ann Rheum Dis, 2019, 78: 736-745. http://d.wanfangdata.com.cn/periodical/5d75890ffea55aee4301e5e11dfdb949
  • 加载中
图(1)
计量
  • 文章访问数:  233
  • HTML全文浏览量:  60
  • PDF下载量:  38
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-06-24
  • 录用日期:  2020-07-30
  • 网络出版日期:  2021-06-07
  • 刊出日期:  2021-07-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!